Study of Harishankara Rasa and its effect on Madhumeha(Type 2 Diabetes)

Phase 3

Completed

• Conditions: Health Condition 1: E119- Type 2 diabetes mellitus without complications

• Registration Number: CTRI/2019/03/018030
• Lead Sponsor: IPGT and RA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-05-22
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 56

Inclusion Criteria

Patients having chief & associated complains of Madhumeha(Prabhuta-Avilamutrata, pipashadhikya, kshudhadhikya etc)

Patients having Fasting blood sugar level >= 126 mg/dl and or PPBS level >= 200 mg/dl

Known patient of Type2 Diabetes and also the preliminarily diagnosed patients on the basis of signs and symptoms of the disease are confirmed by FBS and PPBS.

Exclusion Criteria

Age more than 60 and below 30 years

Prameha pidaka (Diabetic nonhealing wound), Systemic infection, active infection other than superficial mild skin infestation

Secondary Diabetes mellitus.

Patients of any other severe illness.

Diabetes mellitus Type 1

Malignant and accelerated hypertensive.

Other chronic debilitating diseases.

Pregnant woman and expecting conception (within six month)

Lactating mothers.

Patients with fatal diabetic complication like end stage renal disease

Patient with diabetic ketoacidosis

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Monitoring of persistence improvement in glycemic control by Harishankara Rasa after cessation of therapyTimepoint: At the End of Follow Up Period

Secondary Outcome Measures

Name	Time	Method
Improves quality of life of patientsTimepoint: At the End of the Follow up Period